Events
-
-
-
ASCO 2026: Teclistamab extends survival, deepens remissions in relapsed multiple myeloma
-
ASCO 2026: Lancet Commission predict shortfall of 100 million cancer care workers by 2050
-
ASCO 2026: Phase 3 PEAK study could usher in new second-line therapy for GIST
-
ASCO 2026: Personalised vaccine boosts immune activity against brain cancer
-
ASCO 2026: GLP-1s may reduce metastatic progression of certain obesity-related cancers
-
ASCO 2026: Yoga may help cancer survivors sleep better and reduce anxiety, fatigue
-
-
RANZCR launches regional and rural training pathway pilot program
The Royal Australian and New Zealand College of Radiologists (RANZCR) proudly launches the new Regional…
New data informs treatment of blood cancer during pregnancy
Today, Blood Advances published a study revealing that patients with relapsed/refractory (r/r) lymphoma during pregnancy experienced a…
Spanish researchers identify a pigment present in the Santa Pola salt flats as an anticarcinogenic agent
The University of Alicante Applied Biochemistry research group—in collaboration with researchers from the Alicante University Hospital Dr.…
Delaying lung cancer surgery associated with higher risk of recurrence, death
- ASCO 2021: Immunotherapy delays disease recurrence in patients with early-stage, resected non-small cell lung cancer
- ASCO 2021: Antibody drug conjugate shows promise against non-small cell lung cancer resistant to targeted therapy
- Researchers identify potential combination therapy for aggressive lung cancer
Treatment doctor tested on himself can put others into remission
Five years ago, David C. Fajgenbaum, MD, MBA, MSc, both a Penn Medicine researcher and patient, tried an experimental treatment…
JOIN THE ONCOLOGY NETWORK
If you would like even more free news articles, access to our exclusive HCP only content including the latest podcasts from The Oncology Podcast and our Industry Partner Podcasts (including links to all papers and show notes), along with all our other resources, head over to The Oncology Network and sign up - FREE forever for HCPs only.